keyword
https://read.qxmd.com/read/38585296/pharmacokinetic-of-two-oral-doses-of-a-1-20-thc-cbd-cannabis-herbal-extract-in-cats
#21
JOURNAL ARTICLE
Chloe Lyons, Katelyn McEwan, Meara Munn-Patterson, Stephanie Vuong, Jane Alcorn, Alan Chicoine
OBJECTIVE: To determine the pharmacokinetics (PK) of two oral doses of a Cannabis herbal extract (CHE) containing 1:20 THC:CBD in 12 healthy Domestic Shorthair cats. METHODS: Single-dose PK were assessed after oral administration of CHE at low or high dose (2 mg CBD + 0.1 mg THC, or 5 mg CBD + 0.25 mg THC per kg bw, respectively; n  = 6 per group) in fasting cats. Blood samples were drawn up to 48 h following CHE administration...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38583809/cyp2c9-cyp3a-and-cyp2c19-metabolize-%C3%AE-9-tetrahydrocannabinol-to-multiple-metabolites-but-the-metabolism-is-affected-by-human-liver-fatty-acid-binding-protein-fabp1
#22
JOURNAL ARTICLE
King Clyde B Yabut, Yue Winnie Wen, Keiann T Simon, Nina Isoherranen
Δ9-tetrahydrocannabinol (THC) is the psychoactive constituent of cannabis. It is cleared predominantly via metabolism. Metabolism to 11-OH-THC by cytochrome P450 (CYP) 2C9 has been proposed as the main clearance pathway of THC, with the estimated fraction metabolized (fm ) about 70 %. The remaining clearance pathways are not well established, and it is unknown how THC is eliminated in individuals with reduced CYP2C9 activity. The goal of this study was to systematically identify the CYP enzymes contributing to THC clearance and characterize the metabolites formed...
April 5, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38581662/quantitation-of-hexahydrocannabinol-hhc-and-metabolites-in-blood-from-duid-cases
#23
JOURNAL ARTICLE
Robert Kronstrand, Markus Roman, Henrik Green, Michael T Truver
Hexahydrocannabinol (HHC) was first reported in the EU in May 2022. HHC has three chiral carbon atoms, but only (6aR,9R,10aR)-HHC (9R-HHC) and (6aR,9S,10aR)-HHC (9S-HHC) have been encountered in HHC products. The goal of this study was to develop and validate a method for the quantitative analysis of 9R-HHC, 9S-HHC, 11-OH-9R-HHC, 9R-HHC-COOH, 9S-HHC-COOH, and 8-OH-9R-HHC. In addition, an objective was to investigate the immunochemical cross reactivity. Blood samples from DUID-cases screened positive for cannabis using ELISA and confirmed negative for tetrahydrocannabinol (THC), 11-hydroxy-THC, and THC-COOH were reanalyzed with a newly validated HHC method to investigate the presence of HHC and metabolites...
April 6, 2024: Journal of Analytical Toxicology
https://read.qxmd.com/read/38581658/automated-extraction-and-lc-ms-ms-analysis-of-11-nor-9-carboxy-tetrahydrocannabinol-isomers-and-prevalence-in-authentic-urine-specimens
#24
JOURNAL ARTICLE
Larissa K Karas, Courtney Patterson, Zachary J Fuller, Erin L Karschner
11-Nor-9-carboxy-Δ9-tetrahydrocannabinol (Δ9-THCCOOH) is the most frequently detected illicit drug metabolite in the military drug testing program. An increasing number of specimens containing unresolved Δ8-THCCOOH prompted the addition of this analyte to the Department of Defense (DoD) drug testing panel. A method was developed and validated for the quantitative confirmation of the carboxylated metabolites of Δ8- and Δ9-THC in urine samples utilizing automated pipette tip dispersive solid phase extraction and analysis by liquid chromatography tandem mass spectrometry (LC-MS/MS)...
April 6, 2024: Journal of Analytical Toxicology
https://read.qxmd.com/read/38575140/resting-state-brain-networks-under-inverse-agonist-versus-complete-knockout-of-the-cannabinoid-receptor-1
#25
JOURNAL ARTICLE
Hui Li, Qiong Ye, Da Wang, Bowen Shi, Wenjing Xu, Shuning Zhang, Xiaoyang Han, Xiao-Yong Zhang, Garth J Thompson
The cannabinoid receptor 1 (CB1 ) is famous as the target of Δ9 -tetrahydrocannabinol (THC), which is the active ingredient of marijuana. Suppression of CB1 is frequently suggested as a drug target or gene therapy for many conditions (e.g., obesity, Parkinson's disease). However, brain networks affected by CB1 remain elusive, and unanticipated psychological effects in a clinical trial had dire consequences. To better understand the whole brain effects of CB1 suppression we performed in vivo imaging on mice under complete knockout of the gene for CB1 ( cnr1 -/- ) and also under the CB1 inverse agonist rimonabant...
April 4, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38571826/clinical-diagnosis-and-management-of-gradual-onset-cannabis-induced-psychosis-following-the-consumption-of-delta-8-tetrahydrocannabinol
#26
Edward E Denton, Sophia S Jung, Christian Angelo I Ventura
Cannabis-induced psychosis (CIP) is an increasingly acknowledged psychiatric phenomenon observed in vulnerable patients exposed to cannabis. This brief case report details a male patient in his 20s, who presents to the ED with derealization two days after ingesting a gummy worm containing delta-8-tetrahydrocannabinol (Δ8-THC). Two days post-ED discharge, the patient gradually developed symptoms of religious-themed psychosis and was prescribed 10 mg of aripiprazole daily. The patient seemingly recovered within four days of starting treatment...
March 2024: Curēus
https://read.qxmd.com/read/38569457/low-uv-radiation-influenced-dna-methylation-gene-regulation-cell-proliferation-viability-and-biochemical-differentiation-in-the-cell-suspension-cultures-of-cannabis-indica
#27
JOURNAL ARTICLE
Maryam Abedini, Alireza Iranbakhsh, Sara Saadatmand, Mostafa Ebadi, Zahra Oraghi Ardebili
The effect of low artificial Ultraviolet (UV) on the DNA methylation remains controversial. This study addresses how differential photoperiods of UV radiation affect the biochemical and molecular behaviors of Cannabis indica cell suspension cultures. The cell suspensions were illuminated with the compact fluorescent lamps (CFL), emitting a combination of 10% UVB, 30% UVA, and the rest visible wavelengths for 0, 4, 8, and 16 h. The applied photoperiods influenced cell morphological characteristics. The 4 h photoperiod was the most effective treatment for improving biomass, growth index and cell viability percentage while these indices remained non-significant in the 16 h treatment...
March 29, 2024: Journal of Photochemistry and Photobiology. B, Biology
https://read.qxmd.com/read/38568425/antimicrobial-and-antibiofilm-effect-of-cannabinoids-from-cannabis-sativa-against-methicillin-resistant-staphylococcus-aureus-mrsa-causing-bovine-mastitis
#28
JOURNAL ARTICLE
Mayank Roshan, Ila Singh, Ashutosh Vats, Manisha Behera, Dravin Pratap Singh, Devika Gautam, Shiveeli Rajput, Jitesh Tarak, Gopinath Packirisamy, Sachinandan De
Antimicrobial resistance (AMR) poses a serious threat to human, animal, and plant health on a global scale. Search and elimination techniques should be used to effectively counter the spread of methicillin-resistant Staphylococcus aureus (MRSA) infections. With only a few novel drugs in clinical development, the quest for plant-based alternatives to prevent the spread of antibiotic resistance among bacteria has accelerated. Treatment of MRSA infections is challenging owing to rapidly emerging resistance mechanisms coupled with their protective biofilms...
April 3, 2024: International Microbiology: the Official Journal of the Spanish Society for Microbiology
https://read.qxmd.com/read/38561178/pharmacodynamic-effects-following-co-administration-of-cannabinoids-and-opioids-a-scoping-review-of-human-experimental-studies
#29
JOURNAL ARTICLE
David Guy, Jared C Wootten, Michael Wong, Daniel Turski, Mark Lukewich, Abdulrahman Alboog, Abirami R Kandasamy, Jonathan Gregory, Raju Poolacherla
BACKGROUND: Cannabinoids are increasingly used in the management of chronic pain. Although analgesic potential has been demonstrated, cannabinoids interact with a range of bodily functions that are also influenced by chronic pain medications, including opioids. OBJECTIVE: We performed a scoping review of literature on the pharmacodynamic effects following co-administration of cannabinoids and opioids. METHODS: We systematically searched EMBASE, PubMed, and PsycINFO for studies that experimentally investigated the co-effects of cannabinoids and opioids in human-subjects...
April 1, 2024: Pain Medicine
https://read.qxmd.com/read/38561104/pharmacological-evaluation-of-new-generation-oxizid-synthetic-cannabinoid-receptor-agonists
#30
JOURNAL ARTICLE
Monica Patel, Xiaoxi Zheng, Luli R Akinfiresoye, Cassandra Prioleau, Teneille D Walker, Michelle Glass, Julie A Marusich
Synthetic cannabinoid receptor agonists (SCRAs) remain one the largest classes of new psychoactive substances, and are increasingly associated with severe adverse effects and death compared to the phytocannabinoid Δ9 -tetrahydrocannabinol (THC). In the attempt to circumvent the rapid emergence of novel SCRAs, several nations have implemented 'generic' legislations, or 'class-wide' bans based on common structural scaffolds. However, this has only encouraged the incorporation of new chemical entities, including distinct core and linker structures, for which there is a dearth of pharmacological data...
March 30, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38558988/cb-1-cannabinoid-receptor-agonists-induce-acute-respiratory-depression-in-awake-mice
#31
Joshua Watkins, Petra Aradi, Rachel Hahn, Istvan Katona, Ken Mackie, Alexandros Makriyannis, Andrea G Hohmann
Recreational use of synthetic cannabinoid agonists (i.e., "Spice" compounds) that target the Cannabinoid Type 1 receptor (CB 1 ) can cause respiratory depression in humans. However, Δ 9 -tetrahydrocannabinol (THC), the major psychoactive phytocannabinoid in cannabis, is not traditionally thought to interact with CNS control of respiration, based largely upon sparse labeling of CB1 receptors in the medulla and few reports of clinically significant respiratory depression following cannabis overdose. The respiratory effects of CB 1 agonists have rarely been studied in vivo , suggesting that additional inquiry is required to reconcile the conflict between conventional wisdom and human data...
March 13, 2024: bioRxiv
https://read.qxmd.com/read/38557936/development-of-an-lc-ms-ms-method-for-the-determination-of-five-psychoactive-drugs-in-postmortem-urine-by-optimization-of-enzymatic-hydrolysis-of-glucuronide-conjugates
#32
JOURNAL ARTICLE
Tomohito Matsuo, Tadashi Ogawa, Masae Iwai, Katsutoshi Kubo, Fumio Kondo, Hiroshi Seno
PURPOSE: Toxicological analyses of biological samples play important roles in forensic and clinical investigations. Ingested drugs are excreted in urine as conjugates with endogenous substances such as glucuronic acid; hydrolyzing these conjugates improves the determination of target drugs by liquid chromatography-tandem mass spectrometry (LC-MS/MS). In this study, we sought to improve the enzymatic hydrolysis of glucuronide conjugates of five psychoactive drugs (11-nor-9-carboxy-Δ9 -tetrahydrocannabinol, oxazepam, lorazepam, temazepam, and amitriptyline)...
April 1, 2024: Forensic Toxicology
https://read.qxmd.com/read/38554564/patterns-of-delta-8-thc-and-cannabis-uptake-in-nebraska-a-cannabis-prohibition-state
#33
JOURNAL ARTICLE
Ryan Humeniuk, Patrick Habecker, Spencer Cooper-Ohm, Rick A Bevins
BACKGROUND: Following the passage of the 2018 Farm Bill, derived psychoactive cannabis products containing delta 8 tetrahydrocannabinol (THC) have become increasingly popular across the US, particularly in states that lack medical or recreational cannabis programs. Despite this, little is known about patterns of delta 8 THC use. METHODS: A sample of Nebraska residents (a state without legal medical or recreational cannabis) were surveyed to gather data on substance use, including delta 8 THC and cannabis, across the state...
March 29, 2024: International Journal on Drug Policy
https://read.qxmd.com/read/38552484/making-waves-wastewater-based-surveillance-of-cannabis-use
#34
JOURNAL ARTICLE
Lubertus Bijlsma, Bradley Simpson, Cobus Gerber, Alexander L N van Nuijs, Dan Burgard
Monitoring cannabis consumption holds great interest due to the increasing trend towards its legalization for both medicinal and recreational purposes, despite the potential risks and harms involved. Wastewater-based surveillance (WBS) offers a valuable tool for assessing shifts and patterns in drug consumption and to evaluate law enforcement strategies and harm reduction programs. However, WBS-derived cannabis use estimates have been linked to greater uncertainties compared to other drugs, in part due to the many different routes of administration and a substantial excretion of metabolites in faecal matter...
March 25, 2024: Water Research
https://read.qxmd.com/read/38551244/assessing-dental-student-knowledge-on-cannabis-and-demonstrating-the-need-for-cannabis-education
#35
JOURNAL ARTICLE
Jessica S Kruger, John Lepore, Madelyn Mascaro, Gina Mersereau, Alyssa Tzetzo, Daniel J Kruger
PURPOSE: The American Dental Association advocates for dentists' education on therapeutic and legal issues related to medical cannabis. It is important to understand current knowledge of cannabis and cannabinoids and to have a practical knowledge assessment instrument. This exploratory study is the first of its kind to assess dental students' knowledge of cannabis and aims to determine if there is a need for more instruction regarding cannabis in a dental school's curriculum. METHODS: Predoctoral dental students at the University at Buffalo School of Dental Medicine were recruited to participate...
March 29, 2024: Journal of Dental Education
https://read.qxmd.com/read/38546067/a-comparative-analysis-on-the-potential-anticancer-properties-of-tetrahydrocannabinol-cannabidiol-and-tetrahydrocannabivarin-compounds-through-in-silico-approach
#36
JOURNAL ARTICLE
Angelica A Gallardo, Mikaela Rose Gutierrez, Lyka Alexandrea J Gomez, Patricia Arielle O Delos Reyes, Sophia Allison A Dones, Maria Mikaela U Dumbrique, Heather Eena Lim, Maria Isabel H Liquido, Mary Margaret L Macawile, Ella Denese Anne B Maglaqui, Angelica Mae G Manalo, Mark Kevin P Devanadera, Alexis M Labrador
OBJECTIVE: The purpose of this study is to comparatively analyze the anticancer properties of Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Tetrahydrocannabivarin (THCV) using In silico tools. METHODS: Using SwissADME and pkCSM, the physicochemical and pharmacokinetics properties of the cannabinoids were evaluated. Protox-II was utilized for the assessment of their cytotoxicity. The chemical-biological interactions of the cannabinoids were also predicted using the Way2Drug Predictive Server which comprises Acute Rat Toxicity, Adver-Pred, CLC-Pred, and Pass Target Prediction...
March 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38543313/cannabinoid-induced-inhibition-of-morphine-glucuronidation-and-the-potential-for-in-vivo-drug-drug-interactions
#37
JOURNAL ARTICLE
Shelby Coates, Keti Bardhi, Philip Lazarus
Opioids are commonly prescribed for the treatment of chronic pain. Approximately 50% of adults who are prescribed opioids for pain co-use cannabis with their opioid treatment. Morphine is primarily metabolized by UDP-glucuronosyltransferase (UGT) 2B7 to an inactive metabolite, morphine-3-glucuronide (M3G), and an active metabolite, morphine-6-glucuronide (M6G). Previous studies have shown that major cannabis constituents including Δ9 -tetrahydrocannabinol (THC) and cannabidiol (CBD) inhibit major UGT enzymes...
March 18, 2024: Pharmaceutics
https://read.qxmd.com/read/38542886/chemistry-and-pharmacology-of-delta-8-tetrahydrocannabinol
#38
REVIEW
Maged S Abdel-Kader, Mohamed M Radwan, Ahmed M Metwaly, Ibrahim H Eissa, Arno Hazekamp, Mahmoud A ElSohly
Cannabis sativa is one of the oldest plants utilized by humans for both economic and medical purposes. Although the use of cannabis started millennia ago in the Eastern hemisphere, its use has moved and flourished in the Western nations in more recent centuries. C. sativa is the source of psychoactive cannabinoids that are consumed as recreational drugs worldwide. The C21 aromatic hydrocarbons are restricted in their natural occurrence to cannabis (with a few exceptions). Delta-9-tetrahydrocannabinol (Δ9 -THC) is the main psychoactive component in cannabis, with many pharmacological effects and various approved medical applications...
March 11, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38542186/linking-the-autotaxin-lpa-axis-to-medicinal-cannabis-and-the-endocannabinoid-system
#39
REVIEW
Mathias C Eymery, Ahcène Boumendjel, Andrew A McCarthy, Jens Hausmann
Over the past few decades, many current uses for cannabinoids have been described, ranging from controlling epilepsy to neuropathic pain and anxiety treatment. Medicines containing cannabinoids have been approved by both the FDA and the EMA for the control of specific diseases for which there are few alternatives. However, the molecular-level mechanism of action of cannabinoids is still poorly understood. Recently, cannabinoids have been shown to interact with autotaxin (ATX), a secreted lysophospholipase D enzyme responsible for catalyzing lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA), a pleiotropic growth factor that interacts with LPA receptors...
March 12, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38541766/%C3%AE-9-tetrahydrocannabinol-thc-a-critical-overview-of-recent-clinical-trials-and-suggested-guidelines-for-future-research
#40
REVIEW
Peter Pressman, A Wallace Hayes, Julia Hoeng, Diogo A R S Latino, Anatoly Mazurov, Walter K Schlage, Azhar Rana
In this overview, we seek to appraise recent experimental and observational studies investigating THC and its potential role as adjunctive therapy in various medical illnesses. Recent clinical trials are suggestive of the diverse pharmacologic potentials for THC but suffer from small sample sizes, short study duration, failure to address tolerance, little dose variation, ill-defined outcome measures, and failure to identify and/or evaluate confounds, all of which may constitute significant threats to the validity of most trials...
March 7, 2024: Journal of Clinical Medicine
keyword
keyword
8621
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.